Resveratrol Supplementation in Schizophrenia Patients: A Randomized Clinical Trial Evaluating Serum Glucose and Cardiovascular Risk Factors

Background: Patients with schizophrenia (SZ) are generally overweight or obese and have several metabolic disorders. Additionally, such patients have a lower life expectancy and the main cause of their increased mortality is cardiovascular disease (CVD). The objective of this study was to determine...

Descripción completa

Detalles Bibliográficos
Autores principales: Zortea, Karine, Franco, Viviane C., Francesconi, Lenise P., Cereser, Keila M. M., Lobato, Maria Inês R., Belmonte-de-Abreu, Paulo S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772037/
https://www.ncbi.nlm.nih.gov/pubmed/26840331
http://dx.doi.org/10.3390/nu8020073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772037/
https://www.ncbi.nlm.nih.gov/pubmed/26840331
http://dx.doi.org/10.3390/nu8020073

Ejemplares similares